Related Experiment Video
Updated: Jan 14, 2026

07:13
Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
Published on: June 28, 2024
2.1K
Central composite design optimized fluorescent method using dual doped graphene quantum dots for lacosamide
Ahmed Serag1, Rami M Alzhrani2, Reem M Alnemari2
1Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, 11751, Egypt. Ahmedserag777@hotmail.com.
Scientific Reports
|October 21, 2025
Summary
A new method using boron and nitrogen co-doped graphene quantum dots (BN-GQDs) accurately detects lacosamide, an antiepileptic drug. This sensitive and sustainable approach aids in therapeutic drug monitoring and quality control.
Area of Science:
- Analytical Chemistry
- Materials Science
- Pharmacology
Background:
- Lacosamide is a crucial third-generation antiepileptic drug for managing partial-onset seizures.
- Accurate quantification of lacosamide in biological samples and pharmaceuticals is essential for effective treatment and quality control.
- Existing analytical methods may have limitations in sensitivity, sustainability, or applicability.
Purpose of the Study:
- To develop and validate a novel, sensitive, and sustainable analytical method for lacosamide determination.
- To utilize boron and nitrogen co-doped graphene quantum dots (BN-GQDs) for fluorescence-based detection of lacosamide.
- To assess the method's performance according to ICH M10 guidelines and evaluate its environmental impact.
Main Methods:
- Synthesis and characterization of boron and nitrogen co-doped graphene quantum dots (BN-GQDs).
- Development of a fluorescence quenching-based assay for lacosamide detection.
- Optimization of reaction parameters using a central composite design.
- Validation of the analytical method for linearity, limit of detection, accuracy, precision, selectivity, and robustness.
- Application of the method to real human plasma samples and pharmaceutical formulations.
- Environmental impact and sustainability assessment.
Main Results:
- The developed BN-GQDs exhibited strong fluorescence properties, which were quenched by lacosamide.
- The fluorescence quenching mechanism was elucidated using density functional theory and Stern-Volmer analysis.
- The method demonstrated excellent linearity (0.1-5 µg/mL) and a low limit of detection (0.033 µg/mL).
- Validation results met ICH M10 guidelines, confirming accuracy, precision, selectivity, and robustness.
- The method was successfully applied for lacosamide quantification in pharmaceutical formulations and pharmacokinetic studies.
- The proposed method showed significant improvements in environmental impact and sustainability.
Conclusions:
- A novel, sensitive, and validated fluorescence quenching method for lacosamide determination using BN-GQDs has been established.
- The method is suitable for bioanalytical applications, including therapeutic drug monitoring and quality control of lacosamide.
- The use of BN-GQDs offers a sustainable and environmentally friendly alternative for lacosamide analysis.

